2025-2034 Prenatal And Newborn Genetic Testing Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Prenatal And Newborn Genetic Testing Industry Market Size Be by 2025?
The financial valuation of the prenatal and newborn genetic testing sector has witnessed considerable acceleration lately, projecting an expansion from $6.68 billion in the year 2024 to reach $7.6 billion by 2025, reflecting a 13.7% Compound Annual Growth Rate over that span, with historical expansion drivers including enhancements in non-invasive prenatal diagnostic methods, the rising average age of mothers, supportive governmental initiatives and healthcare regulations, alongside a growing patient desire for diagnosis at earlier stages.

What's the Long-Term Growth Forecast for the Prenatal And Newborn Genetic Testing Market Size Through 2029?
Anticipated to expand considerably in the coming years, the market encompassing prenatal and newborn genetic testing is projected to reach a valuation of $12.07 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.3% throughout the forecast duration. This upward trajectory is fundamentally driven by factors such as the broadening scope of genetic test panels, heightened maternal health consciousness, the proliferation of official guidelines for prenatal and newborn screening, a heightened emphasis on identifying infrequent medical conditions, and evolving ethical and regulatory landscapes. Key developments shaping this market in the near future involve the advancements in non-invasive prenatal testing (NIPT), the increasing adoption of whole genome sequencing (WGS) and whole exome sequencing techniques, the incorporation of artificial intelligence (AI) capabilities, the growing relevance of preimplantation genetic testing (PGT), and the expansion of direct-to-consumer genetic testing services.

View the full report here:
https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

What Are the Key Growth Drivers Fueling the Prenatal And Newborn Genetic Testing Market Expansion?
Anticipated upward momentum in the prenatal and newborn genetic testing sectors is poised to be fueled by governmental undertakings and backing for both prenatal diagnostics and the genetic screening of newborns. Government initiatives encompass distinct measures, implemented programs, established policies, or directed projects initiated by authorities at any administrative level-be it municipal, provincial, or federal-with the aim of tackling specific challenges, attaining defined objectives, or enhancing citizen welfare. These governmental efforts concerning prenatal and newborn genetic evaluation serve to assist the populace by facilitating the detection of genetic anomalies or conditions present either in developing fetuses during gestation or in infants immediately following birth. A concrete illustration of this support occurred in June of 2022, when the Australian government committed an annual sum of $1.3 million to the newborn screening endeavor in New South Wales (an eastern Australian state), ensuring unrestricted testing access for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) for every infant born within that state. This extension of newborn genetic testing and screening is projected to screen roughly 100,000 infants annually, potentially rescuing the lives of as many as thirteen newborns at risk of those specific genetic ailments. Consequently, the commitment to and promotion of prenatal and newborn genetic screening programs by governing bodies acts as a significant catalyst for advancing the related testing markets.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

What Are the Key Trends Driving Prenatal And Newborn Genetic Testing Market Growth?
Key players within the prenatal and newborn genetic testing sectors are directing their efforts toward creating novel screening methodologies, notably noninvasive prenatal screening tests, aiming to enhance customer service through greater ease of access and reduced expense. This sophisticated and secure genetic assessment performed during gestation to gauge the likelihood of certain fetal chromosomal deviations is referred to as Noninvasive Prenatal Screening (NIPS) or Noninvasive Prenatal Testing (NIPT). As an illustration, in November 2022, Juno Diagnostics Inc., an American healthcare technology firm, introduced Juno Hazel, a noninvasive prenatal screening examination designed to identify chromosomal irregularities along with accompanying clinical data. The test facilitates improved availability by utilizing a sample collection kit that negates the requirement for drawing blood. Furthermore, the firm intends to integrate physician partnerships and genetic counseling provisions to furnish tailored guidance and educational materials.

How Is the Prenatal And Newborn Genetic Testing Market Segmented?
The prenatal and newborn genetic testingmarket covered in this report is segmented -

1) By Product Type: Consumables; Instruments
2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
3) By Disease: Down Syndrome; ket*onuria; Cystic Fibrosis; Sickle Cell Anemia
4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers

Subsegments:
1) By Consumables: Reagents And Assays; Sample Collection Kits; Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines; Sequencers; Microarray Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp

Which Companies Are Leading the Charge in Prenatal And Newborn Genetic Testing Market Innovation?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, dic*kinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

Which Regions Are Leading the Global Prenatal And Newborn Genetic Testing Market in Revenue?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.